CHLORINE (Cl 2 ) and ozone (O 3 ) are gaseous pollutants that can irritate the human respiratory tract. The time-weighted exposure limit of Cl 2 and O 3 exposure for an 8-h work shift are 0.5 and 0.1 parts per million (ppm) by volume, respectively (1). Short-term exposure of volunteers to Cl 2 concentrations as low as 1.0 ppm and O 3 concentrations as low as 0.12 ppm can cause decrements in forced vital capacity and forced expiratory volume in 1 s (11, 14) . Although the health effects of long-term Cl 2 and O 3 exposure in humans have not been determined, nonneoplastic lesions have been observed in animals chronically exposed to O 3 or Cl 2 . In rats and monkeys, airway lesions resulting from Cl 2 exposure were focused primarily in the nasal cavities (10, 16) , whereas lesions resulting from O 3 exposure were observed in alveolated air spaces (2, 4) . It is possible that these differences in lesion distribution were due to corresponding differences between the uptake patterns of Cl 2 and O 3 .
The uptake of O 3 has been determined by direct sampling of respired gas within the human respiratory tract (5, 6) . These experiments made use of indwelling tubes that limited measurements to only a few large airway sites and undoubtedly disturbed local flow and concentration profiles. To circumvent these problems, the distribution of O 3 uptake in the human respiratory tract can be noninvasively measured by bolus inhalation, an indirect method that utilizes gas sampling at the airway opening alone (7) . Bolus inhalation measurements indicated that the portion of inhaled O 3 absorbed in the upper airways of healthy adult nonsmokers is 80% during quiet nasal breathing compared with 50% during quiet oral breathing. In neither case did O 3 reach the respiratory air spaces (9) . When oral flow was increased to a light exercise condition of 1,000 ml/s, however, 25% of inhaled O 3 reached the respiratory air spaces (8) . Recently, the bolus inhalation method was adapted to Cl 2 . During nasal and oral quiet breathing, Ͼ90% of inhaled Cl 2 was absorbed in the upper airways of healthy nonsmokers (12) .
In the present work the longitudinal distributions of Cl 2 and O 3 were directly compared in the same group of healthy nonsmokers during nasal and oral breathing at respiratory flows of 150, 250, and 1,000 ml/s. Because O 3 is a poorly soluble gas whereas Cl 2 rapidly and reversibly hydrolyzes in aqueous solution, it is hypothesized that increasing the respiratory flow will increase the amount of O 3 but not Cl 2 that reaches the respiratory air spaces during either mode of breathing. The availability of uptake data from these two gases of widely different solubilities also provides an opportunity to study the relative role of their gas phase and mucus phase diffusion resistances. Although a bolus inhalation study of O 3 uptake during oral breathing at 150-1,000 ml/s has been carried out (8) , it was important to repeat these experiments on the same group of subjects and with the identical breathing apparatus used to obtain the Cl 2 bolus inhalation data.
MATHEMATICAL MODELING
As previously described by Nodelman and Ultman (12) , the human airways were modeled as a series of nasal/oral (N/O), pharyngeal (PH), lower airway (LA), and respiratory air space (RA) compartments. On the basis of a simplified solution of the one-dimensional unsteady diffusion equation, Hu and associates (8) derived the relationship between the absorbed fraction (⌳) and the penetration volume (V P ) of a reactive gas bolus inhaled into such a compartmental model. For ease in applying a linear regression analysis, this relationship can be expressed as follows
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where V is the respiratory flow rate and (Ka) i is the product of an overall mass transfer coefficient (K) and the surface-to-volume ratio (a) in compartment i (i.e., N/O, PH, or LA). V P0 , V P1 , and V P2 are the penetration volumes that correspond to the entrance of the N/O, PH, and LA compartments, respectively. I 1 and I 2 are indicator variables defined as follows: I 1 ϭ 1 if V P Ͼ V P1 , and I 1 ϭ 0 otherwise; I 2 ϭ 1 if V P Ͼ V P2 , and I 2 ϭ 0 otherwise. The RA compartment has been omitted from Eq. 1, because the reactive gas reaching this compartment was never sufficient to allow a reliable estimation of (Ka) RA .
The local absorption of Cl 2 and O 3 can be better understood by considering the individual factors that contribute to Ka. As Cl 2 or O 3 absorbs into an airway (or air space), it encounters a diffusion resistance created by a respiratory gas boundary layer and a second resistance imposed by the surrounding mucus (or surfactant) film. The overall resistance to mass transfer within a compartment is equal to the sum of these diffusion resistances (15)
where k g and k ti are the individual mass transfer coefficients in the gas boundary layer and the mucus layer, respectively, and is the equilibrium partition coefficient of Cl 2 or O 3 concentration between gas and mucus. Of particular importance is the fact that k g depends on the geometry and gas flow in the airway lumen.
The value of k g in a specific geometry is often predicted from equations of the following form (15) Sh ϭ mЈRe n Sc p
where mЈ, n, and p are constants. As applied to radial absorption of Cl 2 or O 3 in an airway, the Sherwood (Sh), Reynolds (Re), and Schmidt (Sc) numbers are dimensionless groups defined by
where d is the airway diameter, A is the cross section available for flow, D g is the binary diffusivity of Cl 2 or O 3 in air, and is the kinematic gas viscosity. Combining Eqs. 3 and 4 results in
where
The value of can be approximated by the viscosity of pure air, (D g ) Cl 2 /(D g ) O 3 is estimated to be 0.8 (15) , and p ϭ 0.8-1.3 in human airways (13) . It follows from Eq. 6 that m has similar values for Cl 2 and O 3 and from Eq. 5 that k g is essentially the same for the two gases. In addition, the average value of n for inspiration and expiration is close to unity (13) , so Eq. 5 may be approximated as
where m can be considered to be a constant, whereas a and A depend on compartment geometry. Because k g a/V is essentially the same for both test gases, Eq. 2 can be simultaneously applied to Cl 2 and O 3 (8) where I ϭ 1 when Ka corresponds to Cl 2 absorption and I ϭ 0 when Ka refers to O 3 absorption. Within a particular airway compartment of a particular subject, Eq. 7 implies that k g a/V is constant, and Eq. 8 further implies that plots of 1/Ka vs. 1/V for Cl 2 and for O 3 should be parallel lines with a common slope of V /k g a but different intercepts of (/k ti a) Cl 2 and (/k ti a) O 3 , respectively.
METHODS
Subject population. Five healthy men and five healthy nonpregnant women, all nonsmokers with no history of cardiovascular, pulmonary, and upper airway disease or allergy, were accepted in the investigation. For each subject, nasal volume (V NS ) and cross-sectional area (A NS ), oral volume (V OR ) and cross-sectional area (A OR ), and pharyngeal volume (V PH ) and cross-sectional area (A PH ) were measured by acoustic reflection. Conducting airway volume (V D ) was determined by single-breath nitrogen washout during oral breathing. Lower conducting airway volume (V LA ) was defined as V D Ϫ (V OR ϩ V PH ). The subjects in this study were the same as those in a study of Cl 2 uptake during quiet breathing, for which more detailed descriptions of the screening procedures and the respiratory system volume measurements were previously reported (12) . All procedures employed in the present experiments, including the informed consent of each subject, were approved by the Institutional Review Board of the Pennsylvania State University.
Bolus measurements. The bolus inhalation apparatus consisted of a custom-designed Teflon breathing assembly that monitored respiratory flow and Cl 2 and O 3 concentration and injected boluses containing a peak pollutant concentration of 3.0 ppm Cl 2 or 1.0 ppm O 3 . A mouthpiece or a nasal cannula fixture could be attached to the proximal end of the breathing assembly for oral or nasal breathing maneuvers, respectively. The volume of both fixtures was 20 ml. The detailed design and performance of the bolus inhalation system were described previously (12) . The only modification of the apparatus made in this study was the use of a larger heated pneumotachometer (model 4719, Hans Rudolph) to monitor respired flow in the 1,000 ml/s experiments than was used in the previous quiet breathing experiments.
During a research session, the subject was seated comfortably on a stool, wore noseclips during oral breathing, and maintained a closed mouth during nasal breathing. To carry out a bolus test breath, the subject donned the mouthpiece or nasal cannula, activated the inhalation apparatus by depressing a hand-held switch, and inhaled beginning at functional residual capacity while viewing a computer monitor on which the integrated pneumotachometer signal (i.e., the respired volume) was displayed in real time. Throughout the breath, the subject corrected his or her respiratory flow rate so that respired volume coincided, as closely as possible, with a predrawn isosceles triangle corresponding to equal inspiratory and expiratory flows of 150, 250, or 1,000 ml/s and an inhaled tidal volume of 500 ml. At a predetermined time during inhalation, a Cl 2 -air or O 3 -air bolus was automatically injected into the inspiratory flow. Because the subject always began a test breath at functional residual capacity, the penetration of the bolus into the respiratory system could be systematically varied from breath to breath by changing the injection time. A complete experiment consisted of 50-70 bolus test breaths recorded at penetrations of 0-200 ml.
All 10 subjects participated in six sessions lasting 2-4 h, in which Cl 2 or O 3 bolus measurements were made during nasal and oral breathing at a fixed respired flow of 150, 250, or 1,000 ml/s. For each subject, a Cl 2 session at 250 ml/s was carried out first. This was followed by Cl 2 sessions at 150 and 1,000 ml/s that were performed in an order that was randomized among subjects. The same sessions were then repeated using O 3 as a test gas. Within each session, the order of nasal and oral experiments was randomized, and bolus test breaths were carried out at increasing penetrations in some experiments but at decreasing penetrations in other experiments. To minimize carryover of exposure effects, each session was separated by Ն1 wk.
Data analysis. As previously described in detail (12), the Cl 2 and O 3 concentration curves of each bolus test breath were numerically integrated with respect to respired volume to determine ⌳ (the amount of pollutant absorbed during a single respiratory cycle relative to the inhaled amount) and V P (the mean airway volume that would be reached by inhaled Cl 2 or O 3 molecules relative to the gas sampling point if no absorption occurred). To estimate compartmental values of the overall mass transfer parameter (Ka), a splined linear least-squares regression of Eq. 1 to each subject's ⌳-V P test breath data was separately performed at each respiratory flow, for nasal and oral breathing, and for Cl 2 or O 3 absorption.
Values of V /k g a, (/k ti a) Cl 2 , and (/k ti a) O 3 were estimated within the N/O and PH compartments of each subject by regression of Eq. 8 to the Ka values for Cl 2 and O 3 at the 150, 250, and 1,000 ml/s respired flows. Regression was performed with a nonlinear weighted least-squares Marquart algorithm (Sigma-Plot, SPSS) in which V /k g a, (/k ti a) Cl 2 , and (/k ti a) O 3 were treated as adjustable parameters, and the weights were inversely proportional to the standard errors of the subject's Ka estimates (Fig. 1) . The LA compartment was excluded from this analysis because of extensive absorption of Cl 2 in the more proximal compartments.
To calculate the fraction of inhaled Cl 2 or O 3 that was absorbed within each of the five compartments (⌬⌳), the ⌳ values of Cl 2 or O 3 at the proximal boundaries of the PH, LA, and RA compartments were first calculated from Eq. 1. ⌬⌳ within a compartment was then calculated as the difference between the ⌳ values of Cl 2 or O 3 at the distal and proximal boundaries of the compartment.
A two-tailed Student's t-test was used to compare parameter values between different experimental conditions. Comparisons were made only if at least eight values were available at each condition. Paired comparisons were made when values for all 10 subjects were available in both compared conditions. Otherwise, an unpaired comparison was made. The risk of making a type I error in the comparisons was controlled at ␣ ϭ 0.05.
RESULTS

Characteristics of subjects.
The anthropometric characteristics of the 10 healthy, young, adult nonsmokers who participated in the study are given elsewhere (12) , and their compartmental volumes and average crosssectional areas are given in Table 1 . Whereas V NS was somewhat smaller than V OR (P ϭ 0.18) for the subject population as a whole, there was no correlation between V NS and V OR [coefficient of determination adjusted for number of subjects (r 2 ) ϭ 0.00]. The values of V OR and A OR for different subjects were highly correlated (r 2 ϭ 0.85), the values of V PH and A PH were reasonably correlated (r 2 ϭ 0.50), but the values of V NS and A NS were not correlated (r 2 ϭ 0.00).
Absorbed fraction. In Fig. 2 the ⌳-V P distributions are pooled for all participants at each experimental condition. On average, Cl 2 was absorbed more efficiently than O 3 during nasal and oral breathing. Furthermore, the difference between the absorption efficiency of Cl 2 and O 3 increased with increasing respiratory flow rate during nasal and oral breathing. For example, during nasal breathing at a respiratory flow rate of 150 ml/s, values of ⌳ at the proximal end of the pharynx in an average subject (i.e., V P ϭ 64 ml) were ϳ0.95 for Cl 2 and 0.90 for O 3 . When the respiratory flow was increased to 1,000 ml/s, ⌳ decreased to 0.90 for Cl 2 and 0.45 for O 3 . Similarly, during oral breathing at 150 ml/s, the values of ⌳ at the proximal end of the pharynx in an average subject (i.e., V P ϭ 74 ml) were 0.95 for Cl 2 and 0.80 for O 3 , but ⌳ decreased to 0.85 for Cl 2 and 0.25 for O 3 when the respiratory flow increased to 1,000 ml/s. Figure 2 also indicates that Cl 2 absorption was similar during nasal and oral breathing but O 3 absorption was more efficient during nasal breathing, particularly at the higher respiratory flows. For example, ⌳ for Cl 2 at the proximal boundary of the pharynx was 0.95 during nasal and oral breathing at 150 ml/s and 0.90 during nasal breathing and 0.85 during oral breathing at 1,000 ml/s. In contrast, the corresponding values of ⌳ for O 3 were 0.90 during nasal breathing and 0.80 during oral breathing at 150 ml/s and 0.45 during nasal breathing and 0.25 during oral breathing at 1,000 ml/s. As a result, a higher dose of inspired O 3 was absorbed in the PH, LA, and RA compartments during oral breathing than during nasal breathing.
⌬⌳ of Cl 2 and O 3 in each of the four airway compartments is shown in Fig. 3 . Relative to O 3 , the dose distribution of Cl 2 exhibits a much weaker dependence on respiratory flow rate. For example, at a resting respiratory flow rate of 150 ml/s, ϳ95% of the inspired Cl 2 and 80-90% of the inspired O 3 was absorbed in the N/O compartment and Ͻ1% of the inspired Cl 2 or O 3 was absorbed in the RA. At a higher respiratory flow rate of 1,000 ml/s, the Cl 2 dose distribution changed only slightly: 90 and 85% of the inspired Cl 2 was absorbed in the NS and OR compartments, respectively, and Ͻ1% of the inspired Cl 2 was absorbed in the RA. The dose distribution of O 3 , however, changed substantially: only 45 and 25% of the inspired O 3 was absorbed in the NS and OR compartments, respectively, and 5-10% of the inspired O 3 was absorbed in the RA.
Mass transfer coefficients. Table 2 summarizes the Ka values that were calculated from the individual regression of each subject's ⌳-V P distribution. At all three respiratory flow rates, the values of Ka were significantly higher for Cl 2 than for O 3 in the NS and OR compartments (P Ͻ 0.04), but not in the PH and LA compartments (P Ͼ 0.1). Furthermore, the values of Ka for O 3 were always significantly higher in the NS compartment than in the OR compartment (P Ͻ 0.02) but were similar in the PH compartment during both modes of breathing (P Ͼ 0.2). In contrast, the Ka values for Cl 2 were larger in the NS compartment than in the OR compartment at the higher respiratory flow rates (P Ͻ 0.04), but not at the lowest respiratory flow (P ϭ 0.5). Because of extensive absorption of Cl 2 and O 3 in the proximal compartments, there was a paucity of ⌳-V P data in the PH and LA compartments, resulting in large uncertainties in the Ka values. In some subjects, there were insufficient data to even compute Ka in the PH and LA compartments. Table 3 summarizes the values of the gas phase absorption parameter (k g a/V ) and the mucus phase absorption parameter (k ti a/) that were estimated by regression of each subject's Ka values in the NS, OR, and PH compartments according to Eq. 8. Because of extensive absorption in the NS and OR compartments, however, the Ka data were only sufficient to compute absorption parameters for the PH compartment in one subject during nasal breathing and two subjects during oral breathing. Theoretically, k g a/V is essentially the same for Cl 2 and O 3 , but k ti a/ can have separate values for the two gases. In fact, the value of (/k ti a)Cl 2 was so small that the tissue phase did not limit the rate of Cl 2 absorption. On the other hand, (k ti a/)O 3 did have a significant effect on O 3 absorption. As suggested by the standard deviations in Table 3 , there was no significant difference between k g a/V values in the NS and OR compartments (P ϭ 0.9), but the value of (k ti a/)O 3 was larger in the NS compartment than in the OR compartment (P ϭ 0.09).
DISCUSSION
The primary objective of this research was to determine how the physical-chemical properties of Cl 2 and O 3 affect their uptake distributions in the intact respiratory tract. To be absorbed into the epithelial lining fluid (ELF), both gases must overcome the in-series diffusion resistances of the respired gas and adjacent liquid film (Eq. 2). Because both gases have similar diffusion coefficients in respired air, their gas phase diffusion resistances should be similar, an expectation that is illustrated by the parallelism of the lines in the (1/Ka)-(1/V ) correlation (Fig. 1) . It follows that differences between the absorption rates of these two gases are due to their interactions with the ELF.
The physical solubilities of Cl 2 and O 3 in ELF are low, but Cl 2 reacts with water to form hypochlorous and hydrochloride acids, whereas O 3 irreversibly oxidizes biochemical substrates such as albumin, fatty acids, urate, and ascorbate. Because of the abundance of water in ELF, the Cl 2 hydrolysis reaction occurs rapidly and with such a large equilibrium constant that the concentration of Cl 2 in the form of the acid ions is ϳ120,000 times the concentration of molecular Cl 2 (12) . In other words, hydrolysis suppresses the backpressure of Cl 2 everywhere in ELF and thereby minimizes the diffusion resistance of Cl 2 in ELF. The concentrations of oxidizable substrates in ELF are low, however, so the reaction rate of O 3 is not sufficiently fast to eliminate the backpressure of O 3 as an impediment to absorption. One would therefore expect that the diffusion resistance of Cl 2 in ELF would be smaller than that of O 3 . This is exemplified by the intercepts of the (1/Ka)-(1/V ) correlation (Fig. 1) .
Because the liquid phase diffusion resistance of Cl 2 is so small, the absorption rate of Cl 2 is generally limited by gas phase diffusion, which is proportional to respiratory flow rate. This is exactly counterbalanced by the inverse dependence of bolus residence time on respiratory flow rate, explaining why the ⌳-V P distribution for Cl 2 is relatively insensitive to respiratory flow (Fig. 2) . On the other hand, the O 3 absorption rate is sensitive to diffusion through ELF, which is independent of respiratory flow rate. Therefore, a progressive reduction of absorption occurs in the proximal airways as increases in respiratory flow shorten the residence time of a bolus. This is the basis of the progressive distal shift of the O 3 distribution that occurs as respiratory flow rate increases.
At the lowest nasal respiratory flow of 150 ml/min, the gas phase diffusion resistances of Cl 2 and O 3 dominate their liquid phase resistances, so that the ⌳-V P distributions for the two gases are similar (Fig. 2) . During an oral flow of 150 ml/min, however, a significant resistance of O 3 diffusion through ELF causes a distal shift of the O 3 distribution relative to the corresponding Cl 2 distribution. Because the saliva in the mouth probably lacks much of the antioxidant capacity of nasal mucus, it is not surprising that the diffusion resistance of O 3 is more important in the mouth than in the nose. The hydrolysis of Cl 2 , on the other hand, should suppress the diffusion resistance of the liquid film in the nose and the mouth.
The specific values of the liquid phase resistance (/k ti a) for O 3 were 0.042 s in the nasal compartment and 0.18 s in the oral compartment, whereas /k ti a values estimated for Cl 2 were not significantly different from zero. Because of this, the gas phase resistance of Cl 2 accounted for 100% of the overall diffusion resistance in the nasal and oral compartments at all respiratory flow rates. On the other hand, the gas phase resistance of O 3 at respiratory flow rates of 150, 250, and 1,000 ml/s made contributions to the overall nasal diffusion resistance of 86, 79, and 49%, respectively, and contributions to the overall oral diffusion resistance of 64, 51, and 21%, respectively. Although Ka values in the nose and mouth were generally larger for Cl 2 than for O 3 , most paired comparisons of Ka values in the PH and LA compartments showed a lack of significant differences between Cl 2 and O 3 . A post hoc power analysis indicated, however, that the probability of a type II error (i.e., falsely concluding that the values of Ka for Cl 2 and O 3 were similar) was ϳ0.75. Reduction of this probability to an acceptable level of 0.2 would require testing approximately twice as many subjects or improving the precision of the test breath concentration data, possibly by increasing the peak inhaled bolus concentration.
A substantial dose of O 3 was absorbed in the LA compartment under all experimental conditions and in the RA compartment during oral breathing at the highest respiratory flow rate of 1,000 ml/s (Fig. 3) . This suggests that an increase in respiratory flow coupled with a switch from nasal to oral breathing, as normally occurs during exercise, is likely to cause a distal shift in the O 3 dose distribution, which increases the likelihood of damage to alveolar and bronchiolar tissues. In contrast, inspired Cl 2 was primarily absorbed in the NS and OR compartments. Even during oral breathing at a respiratory flow of 1,000 ml/s, Ͼ85% of the inspired Cl 2 was still absorbed in the OR compartment compared with only 25% of the inspired O 3 (Fig. 3) . Because this result was consistent for all 10 subjects, it is likely that Cl 2 -induced tissue damage is localized in the upper airways of the human respiratory tract, irrespective of the mode of breathing or respiratory flow rate.
The measurements of O 3 bolus inhalation in this study are consistent with the results of previous studies that used healthy nonsmokers. Hu et al. (8) showed that ⌳ was ϳ0.50 at a V P of 50 ml and 0.90 at a V P of 170 ml during oral breathing at 150 ml/s. When the oral flow was increased to 1,000 ml/s, ⌳ decreased to ϳ0.10 at a V P of 50 ml and to 0.75 at a V P of 170 ml. In the present study the corresponding values of ⌳ were ϳ0.60 and 0.95 during oral breathing at 150 ml/s and 0.10 and 0.90 during oral breathing at 1,000 ml/s (Fig.  2) . Therefore, the ⌳ values obtained during oral breathing of O 3 in this study were slightly higher than those reported previously. This previous study did not include female subjects, who are known to exhibit higher ⌳ values than men during oral breathing (3). During nasal breathing at a respired flow rate of 250 ml/s, Kabel et al. (9) reported ⌳ of ϳ0.70 at a V P of 50 ml and 0.90 at a V P of 170 ml. In this study, corresponding values of ⌳ were ϳ0.65 and 0.95. Thus the ⌳ values obtained during nasal quiet breathing were quite similar in the present and the previous study.
Previous studies have shown that Cl 2 and O 3 uptake rates during quiet breathing are related to airway geometry because of its effect on the gas phase diffusion resistance (3, 12) . To further explore this phenomenon in the present study, Eq. 7 was applied to the N/O compartment. By writing a in an explicit manner, Eq. 7 becomes
where V, S, and A are the airway volume, surface area, and average cross-sectional area, respectively. If the geometric shape of an airway was the same in everyone, then the S/A ratio would be a constant from subject to subject and k g a/V would be inversely proportional to the airway volume. To test this possibility, a weighted log-log regression of the individual subject's values of k g a/V to the corresponding values of V was performed in the NS as well as in the OR compartment. Weights were computed as the squared reciprocal of the standard error of each value of k g a/V . The results of the two regressions were as follows (Fig. 4 http://jap.physiology.org/ Downloaded from ment described by Eq. 11, variations in (k g a/V ) NS were not as well predicted by variations in V NS (r 2 ϭ 0.61), and the exponent on V NS deviated from Ϫ1.0 (P ϭ 0.033) by a greater amount. These results suggest that the shape of the nasal compartment was not constant among the 10 subjects. This conclusion is also consistent with the fact that V NS was not correlated with A NS (r 2 ϭ 0.00). At the highest respiratory flow employed in this study, the spatial resolution of the bolus inhalation method was limited. During each test breath, a pulse of Cl 2 -air (or O 3 -air) was injected into the inhaled airstream by using a miniature solenoid valve that was opened for 0.1 s. At the lowest airflow of 150 ml/s, the Cl 2 pulse formed an inhaled bolus by mixing with the 15 ml of air that passed the injection point during 0.1 s. At the highest airflow of 1,000 ml/s, the Cl 2 pulse mixed with 100 ml of air to form the inhaled bolus. In other words, the volume of the inhaled Cl 2 -air (or O 3 -air) bolus ranged from 15 ml at 150 ml/s, which was smaller than the smallest compartmental volume, to 100 ml at 1,000 ml/s, which was somewhat larger than the largest compartmental volume (Table 1 ). In addition to dispersive mixing of the inhaled bolus, dispersion occurred as the bolus was convected within the respiratory system (12) . This further compromised the spatial resolution of the absorption data.
Summary. The longitudinal distribution of Cl 2 and O 3 absorption was measured by the bolus inhalation method in 10 subjects during nasal and oral breathing at flow rates of 150, 250, and 1,000 ml/s. Irrespective of the mode of breathing and respiratory flow rate, Ͼ95% of the inspired Cl 2 was absorbed in the upper airways, whereas the dose delivered to the lower airways was Ͻ5%. In contrast, the dose distribution of O 3 was relatively sensitive to the mode of breathing as well as to respiratory flow rate. As respiratory flow increased, the O 3 dose delivered to the upper airways ranged from 95 to 50%, whereas the dose delivered to the LA ranged from 0 to 35%. These differences between Cl 2 and O 3 dosimetry were attributed to the greater tissue phase resistance of O 3 than of Cl 2 . During quiet oral breathing, tissue phase diffusion resistance accounted for ϳ50% of the overall absorption resistance of O 3 but for virtually none of the overall absorption resistance of Cl 2 . The lack of a tissue phase resistance for Cl 2 probably resulted from its rapid hydrolysis in the airway mucosa. The gas phase resistances of Cl 2 and O 3 were similar and were related in an inverse manner to the volumes of the oral and nasal cavities.
